- Home
- AEF vs OSUR Comparison
AEF vs OSUR Comparison
Compare AEF & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEF
- OSUR
- Stock Information
- Founded
- AEF 1989
- OSUR 2000
- Country
- AEF United States
- OSUR United States
- Employees
- AEF N/A
- OSUR N/A
- Industry
- AEF Finance/Investors Services
- OSUR Medical/Dental Instruments
- Sector
- AEF Finance
- OSUR Health Care
- Exchange
- AEF Nasdaq
- OSUR Nasdaq
- Market Cap
- AEF 196.1M
- OSUR 223.0M
- IPO Year
- AEF N/A
- OSUR 1986
- Fundamental
- Price
- AEF $5.28
- OSUR $2.51
- Analyst Decision
- AEF
- OSUR Hold
- Analyst Count
- AEF 0
- OSUR 2
- Target Price
- AEF N/A
- OSUR $5.50
- AVG Volume (30 Days)
- AEF 92.5K
- OSUR 442.1K
- Earning Date
- AEF 01-01-0001
- OSUR 05-07-2025
- Dividend Yield
- AEF 7.13%
- OSUR N/A
- EPS Growth
- AEF N/A
- OSUR N/A
- EPS
- AEF 0.57
- OSUR N/A
- Revenue
- AEF N/A
- OSUR $161,626,000.00
- Revenue This Year
- AEF N/A
- OSUR N/A
- Revenue Next Year
- AEF N/A
- OSUR $7.55
- P/E Ratio
- AEF $8.86
- OSUR N/A
- Revenue Growth
- AEF N/A
- OSUR N/A
- 52 Week Low
- AEF $4.40
- OSUR $2.69
- 52 Week High
- AEF $5.53
- OSUR $5.59
- Technical
- Relative Strength Index (RSI)
- AEF 61.21
- OSUR 27.71
- Support Level
- AEF $5.20
- OSUR $2.42
- Resistance Level
- AEF $5.35
- OSUR $3.09
- Average True Range (ATR)
- AEF 0.07
- OSUR 0.11
- MACD
- AEF 0.03
- OSUR -0.03
- Stochastic Oscillator
- AEF 84.38
- OSUR 13.24
About AEF abrdn Emerging Markets Equity Income Fund Inc.
ABERDEEN EMERGING MARKETS EQUITY INCOME FUND, INC. is a closed-end investment company. The Fund's investment objective is to seek to provide both current income and long-term capital appreciation. The Fund invests in a range of sectors, including financials, consumer staples, utilities, consumer discretionary, materials, energy, information technology, private equity, communication services, healthcare, real estate, and industrials.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.